An Exceptional Broad-Spectrum Nanobiocide for Multimodal and Synergistic Inactivation of Drug-Resistant Bacteria

被引:29
|
作者
Xue, Ke [1 ]
Yang, Cuihong [2 ]
Wang, Chun [1 ]
Liu, Yang [1 ]
Liu, Jianfeng [2 ]
Shi, Linqi [1 ]
Zhu, Chunlei [1 ]
机构
[1] Nankai Univ, Coll Chem, Inst Polymer Chem, Key Lab Funct Polymer Mat,Minist Educ,State Key L, Tianjin 300071, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Inst Radiat Med, Tianjin Key Lab Radiat Med & Mol Nucl Med, Tianjin 300192, Peoples R China
来源
CCS CHEMISTRY | 2022年 / 4卷 / 01期
基金
中国国家自然科学基金;
关键词
nanobiocides; photothermal materials; in situ surface polymerization; drug-resistant bacteria; multimodal and synergistic therapy; FATTY-ACIDS; NANOPARTICLES; NANOMATERIALS; THERAPY;
D O I
10.31635/ccschem.021.202000714
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
This study reports the fabrication of a novel photothermal material formed via the physical blending of excess lauric acid (LA) and cupric acetate, followed by efficient ligand exchange. Surprisingly, the copper-LA complex exhibited a 12-fold enhancement of the molar extinction coefficient in the near-infrared (NIR) region relative to aqueous cupric acetate. Inspired by this interesting finding, we formulated these photothermal materials into colloidally dispersed nanoparticles via a technique that combined nanoprecipitation and in situ surface polymerization for antibacterial studies. The resultant nanoparticles exhibited rapid and stable photothermal responses to NIR irradiation, with a 4-fold enhanced photothermal conversion efficiency relative to aqueous cupric acetate. Since a positively charged monomer was incorporated during in situ surface polymerization, these positively charged nanoparticles were ingested efficiently and subsequently digested by drug-resistant bacteria. By combining the LA-mediated membrane-damaging effect, copper-mediated Fenton-like reaction, as well as the photothermal effect of the copper-LA complex, a broad-spectrum, multimodal, and synergistic antibacterial effect was achieved both in vitro and in vivo, with the killing efficiency up to 99.99% for ampicillin-resistant Escherichia coli (Amp' E. coli) and 99.9999% for methicillin-resistant Staphylococcus aureus (MRSA). Our newly developed nanobiocide represents a class of exceptional broad-spectrum antibacterial materials, holding great potential for treating drug-resistant infections in clinical settings. [GRAPHICS] .
引用
收藏
页码:272 / 285
页数:14
相关论文
共 50 条
  • [31] Drug-resistant bacteria ranked
    Willyard, Cassandra
    NATURE, 2017, 543 (7643) : 15 - 15
  • [32] Wide-Spectrum Nano-Antibiotics Based on TPA-Py@AuNCs⊂BSA for Multimodal Synergistic Therapy of Drug-Resistant Bacteria and Wound Infections
    Xu, Feng-Rui
    Zhang, Guo-Ling
    Zhang, Kai
    Chen, Pu
    Wang, Qianqian
    Pan, Yuezhe
    Tang, Ben Zhong
    Feng, Hai-Tao
    AGGREGATE, 2025, 6 (02):
  • [33] BATTLING DRUG-RESISTANT BACTERIA
    Erickson, Britt E.
    CHEMICAL & ENGINEERING NEWS, 2014, 92 (40) : 27 - 29
  • [34] Battling drug-resistant bacteria
    Dutton, G
    GENETIC ENGINEERING NEWS, 1998, 18 (02): : 9 - +
  • [35] Photodynamic inactivation of drug-resistant bacteria isolated from diabetic foot ulcers
    Kashef, N.
    Djavid, Esmaeeli G.
    Siroosy, M.
    Khani, Taghi A.
    Zokai, Hesami F.
    Fateh, M.
    IRANIAN JOURNAL OF MICROBIOLOGY, 2011, 3 (01) : 36 - 41
  • [36] Dual antimicrobial actions on modified fabric leads to inactivation of drug-resistant bacteria
    Chen, Jincan
    Wang, Weijie
    Hu, Ping
    Wang, Dong
    Lin, Fan
    Xue, Jingping
    Chen, Zhuo
    Iqbal, Zafar
    Huang, Mingdong
    DYES AND PIGMENTS, 2017, 140 : 236 - 243
  • [37] BROAD-SPECTRUM SYNERGISTIC ANTIVIRAL ACTIVITY OF SELENAZOFURIN AND RIBAVIRIN
    KIRSI, JJ
    MCKERNAN, PA
    BURNS, NJ
    NORTH, JA
    MURRAY, BK
    ROBINS, RK
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 26 (04) : 466 - 475
  • [38] ATOVAQUONE - A NOVEL BROAD-SPECTRUM ANTIINFECTIVE DRUG
    HUDSON, AT
    PARASITOLOGY TODAY, 1993, 9 (02): : 66 - 68
  • [39] Broad-Spectrum Antivirals and Antiviral Drug Combinations
    Oksenych, Valentyn
    Kainov, Denis E.
    VIRUSES-BASEL, 2022, 14 (02):